Literature DB >> 10216834

Evaluation of a novel molecular vibration-based descriptor (EVA) for QSAR studies: 2. Model validation using a benchmark steroid dataset.

D B Turner1, P Willett, A M Ferguson, T W Heritage.   

Abstract

The EVA molecular descriptor derived from calculated molecular vibrational frequencies is validated for use in QSAR studies. EVA provides a conformationally sensitive but, unlike 3D-QSAR methods such as CoMFA, superposition-free descriptor that has been shown to perform well with a wide range of datasets and biological endpoints. A detailed study is made using a benchmark steroid dataset with a training/test set division of structures. Intensive statistical validation tests are undertaken including various forms of crossvalidation and repeated random permutation testing. Latent variable score plots show that the distribution of structures in reduced dimensional space can be rationalized in terms of activity classes and that EVA is sensitive to structural inconsistencies. Together, the findings indicate that EVA is a statistically robust means of detecting structure-activity correlations with performance entirely comparable to that of analogous CoMFAs. The EVA descriptor is shown to be conformationally sensitive and as such can be considered to be a 3D descriptor but with the advantage over CoMFA that structural superposition is not required. EVA has the property that in certain situations the conformational sensitivity can be altered through the appropriate choice of the EVA sigma parameter.

Entities:  

Mesh:

Year:  1999        PMID: 10216834     DOI: 10.1023/a:1008012732081

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  19 in total

1.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Authors:  R D Cramer; D E Patterson; J D Bunce
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

2.  Evaluation of a novel infrared range vibration-based descriptor (EVA) for QSAR studies. 1. General application.

Authors:  D B Turner; P Willett; A M Ferguson; T Heritage
Journal:  J Comput Aided Mol Des       Date:  1997-07       Impact factor: 3.686

3.  MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: a comparative 3D QSAR study in a series of steroids.

Authors:  G Bravi; E Gancia; P Mascagni; M Pegna; R Todeschini; A Zaliani
Journal:  J Comput Aided Mol Des       Date:  1997-01       Impact factor: 3.686

4.  Objective models for steroid binding sites of human globulins.

Authors:  J Schnitker; R Gopalaswamy; G M Crippen
Journal:  J Comput Aided Mol Des       Date:  1997-01       Impact factor: 3.686

5.  Receptor surface models. 2. Application to quantitative structure-activity relationships studies.

Authors:  M Hahn; D Rogers
Journal:  J Med Chem       Date:  1995-06-09       Impact factor: 7.446

6.  Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark.

Authors:  A N Jain; K Koile; D Chapman
Journal:  J Med Chem       Date:  1994-07-22       Impact factor: 7.446

7.  PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.

Authors:  B Waszkowycz; D E Clark; D Frenkel; J Li; C W Murray; B Robson; D R Westhead
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

8.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

9.  Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma.

Authors:  J F Dunn; B C Nisula; D Rodbard
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

10.  Steroid-protein interactions. Human corticosteroid binding globulin: some physicochemical properties and binding specificity.

Authors:  K E Mickelson; J Forsthoefel; U Westphal
Journal:  Biochemistry       Date:  1981-10-13       Impact factor: 3.162

View more
  6 in total

1.  Evaluation of the EVA descriptor for QSAR studies: 3. The use of a genetic algorithm to search for models with enhanced predictive properties (EVA_GA).

Authors:  D B Turner; P Willett
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  3D-QSAR illusions.

Authors:  Arthur M Doweyko
Journal:  J Comput Aided Mol Des       Date:  2004 Jul-Sep       Impact factor: 3.686

3.  Ligand intramolecular motions in ligand-protein interaction: ALPHA, a novel dynamic descriptor and a QSAR study with extended steroid benchmark dataset.

Authors:  Kari Tuppurainen; Marja Viisas; Mikael Peräkylä; Reino Laatikainen
Journal:  J Comput Aided Mol Des       Date:  2004-03       Impact factor: 3.686

4.  Examining the predictive accuracy of the novel 3D N-linear algebraic molecular codifications on benchmark datasets.

Authors:  César R García-Jacas; Ernesto Contreras-Torres; Yovani Marrero-Ponce; Mario Pupo-Meriño; Stephen J Barigye; Lisset Cabrera-Leyva
Journal:  J Cheminform       Date:  2016-02-25       Impact factor: 5.514

5.  QuBiLS-MAS, open source multi-platform software for atom- and bond-based topological (2D) and chiral (2.5D) algebraic molecular descriptors computations.

Authors:  José R Valdés-Martiní; Yovani Marrero-Ponce; César R García-Jacas; Karina Martinez-Mayorga; Stephen J Barigye; Yasser Silveira Vaz d'Almeida; Hai Pham-The; Facundo Pérez-Giménez; Carlos A Morell
Journal:  J Cheminform       Date:  2017-06-07       Impact factor: 5.514

6.  CoMFA, CoMSIA and eigenvalue analysis on dibenzodioxepinone and dibenzodioxocinone derivatives as cholesteryl ester transfer protein inhibitors.

Authors:  Xu-qiong Xiong; Dong-mei Zhao; Peng-fei Bu; Yang Liu; Jin-hong Ren; Jian Wang; Mao-sheng Cheng
Journal:  Molecules       Date:  2008-08-22       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.